News
Serena Williams divides fans as she reveals unexpected benefits of using GLP-1 weight loss medication
Tennis champion Serena Williams has divided the internet after revealing she’s been using a GLP-1 weight loss drug. The 23-time Grand Slam champion says she has lost 31 pounds since taking Zepbound, which shares the same active ingredient as Mounjaro.
Serena Williams reveals dramatic 31-POUND weight loss with new drug after sparking concern with 'too thin' photos
The 43-year-old tennis legend has opened up on her drastic weight loss journey, revealing that she has shed 31 pounds over the course of the past year. But admitted that she's had a helping hand.
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Novo Nordisk's weight-loss medication, Wegovy, uses semaglutide, which only focuses on GLP-1. That difference translated to greater weight loss with Zepbound than Wegovy, a recent study ...
People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical ...
Now, approved for weight loss under the name Zepbound, the drug is available in six doses—2.5, 5, 7.5, 10, 12.5, and 15 milligrams, according to Eli Lilly, which makes the injectable medication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback